PATENT CLAIM ANALYSIS

Application Number: 15984747
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "259300"]

Abstract:
Compounds and salts thereof that are useful as JAK kinse inhibitors are described herein. Also provided are pharmaceutical compositions that include such a JAK inhibitor and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.

Claim (Index 28):
A compound of  claim 1  or a pharmaceutically acceptable salt or stereoisomer thereof, for use in the treatment of an inflammatory disease.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 93.0
- Lexical Diversity: 1.37778
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13099179', '12813142', '13382145', '15139164', '13004808']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.779265529300501
- 35 USC 102 Novelty (BERT): 0.5420594427755684
- Combined Prediction Score: 0.7555449206480077
- Mean Citation Score: 356.240646
- Max Citation Score: 370.0746
- Similarity Product: 270.7658732781172

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test